DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 143 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$6,361,000
+110.6%
1,969,225
+1.7%
0.24%
+75.0%
Q3 2016$3,020,000
+17.3%
1,935,9420.0%0.14%
+38.6%
Q2 2016$2,575,000
-88.9%
1,935,942
-56.0%
0.10%
-89.8%
Q1 2016$23,182,000
-31.4%
4,398,862
+2.2%
0.99%
-28.0%
Q4 2015$33,797,000
+2.3%
4,305,288
+10.1%
1.37%
+7.2%
Q3 2015$33,046,000
+22.4%
3,910,721
+58.6%
1.28%
+42.2%
Q2 2015$26,993,000
-51.3%
2,465,129
-37.9%
0.90%
-50.0%
Q1 2015$55,475,000
-14.9%
3,968,155
+2.9%
1.80%
-23.2%
Q4 2014$65,158,000
+25.0%
3,857,805
-0.6%
2.34%
+23.3%
Q3 2014$52,107,000
+11.3%
3,882,805
+5.7%
1.90%
+0.8%
Q2 2014$46,817,000
-11.4%
3,674,838
-17.3%
1.88%
-12.7%
Q1 2014$52,839,000
-8.5%
4,444,027
+6.3%
2.16%
-27.9%
Q4 2013$57,750,000
+52.6%
4,181,743
+92.6%
2.99%
+69.9%
Q3 2013$37,853,000
-0.7%
2,171,744
-7.8%
1.76%
-2.0%
Q2 2013$38,132,0002,354,9631.80%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Consonance Capital Management LP 6,575,000$21,237,0002.26%
AIGH Capital Management LLC 1,650,256$5,330,0001.12%
BVF INC/IL 8,383,645$27,079,0001.02%
GUARDIAN POINT CAPITAL, LP 1,200,000$3,876,0000.97%
Tri Locum Partners LP 1,210,863$3,911,0000.97%
Altium Capital Management LP 972,327$3,141,0000.87%
Worth Venture Partners, LLC 387,141$1,250,0000.61%
DAFNA Capital Management LLC 459,260$1,483,0000.35%
SABBY MANAGEMENT, LLC 530,000$1,712,0000.33%
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC 173,110$559,0000.24%
View complete list of INFINITY PHARMACEUTICALS INC shareholders